Analysis of the profiles of patients with dual pathology attending addiction centers, mental health centers, and a coordinated service

  • Juan José Mancheño-Barba Community Mental Health Units, Juan Ramón Jiménez Hospital, Huelva (Spain)
  • Sergio Navas-León Department of Clinical and Experimental Psychology, University of Huelva
  • María-Luisa Gutiérrez-Lopez Community Mental Health Units, Juan Ramón Jiménez Hospital, Huelva
  • Ana de la Rosa-Cáceres Department of Clinical and Experimental Psychology, University of Huelva
  • Pilar Cáceres-Pachón Department of Clinical and Experimental Psychology, University of Huelva
  • Oscar Martin Lozano University of Huelva

Abstract

Dual patients are usually treated in drug users services, mental health units, or both. However, each patient can choose the service to receive the health care. The aim of this study is to analyze the similarities and differences of the patient profiles that are treated in each one of these centers. The sample consists of 170 patients diagnosed with dual pathology treated at Servicio Provincial de Drogodependencias de Huelva (SPDH) and Unidades de Salud Mental Comunitaria (USMC) in the province of Huelva. In SPDH, higher prevalence of patients with cocaine and heroin dependence profile was observed (35.9% vs 2% in MH and 16.4% in coordinated). In USMC there is higher prevalence of patients with cannabis dependence profile (41.2% vs 9.4% in the DU and 16.4% in the coordinated service). The odds ratio for patients with hypomanic episodes was 2,879 (p <0.05) in SPDH compared to other services. Odds ratio observed for manic episodes was 0.483 (p <0.05) in SPDH. Patients with comorbid psychotic disorders are more prevalent in USMC compared to SPDH services (66% vs 37.5%). The differences observed in the profiles should be considered in the care planning of these centers.

Downloads

Download data is not yet available.

References

American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th Edition). Washington, DC. (Traducción castellana: Manual diagnóstico y estadístico de los trastornos mentales DSM-5. Madrid: Panamericana, 2014).

Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … Babín, F. (2013). Estudio Madrid sobre prevalencia y características de los pacientes con patología dual en tratamiento en las redes de salud mental y de atención al drogodependiente. Adicciones, 25, 191–200. https://doi.org/10.20882/adicciones.59

Balhara, Y. P. S., Lev-Ran, S., Martínez-Raga, J., Benyamina, A., Singh, S., Blecha, L. y Szerman, N. (2016). State of Training, Clinical Services, and Research on Dual Disorders Across France, India, Israel, and Spain. Journal of Dual Diagnosis, 12(3–4), 252–260. https://doi.org/10.1080/15504263.2016.1254309

Carmiol, N., Peralta, J. M., Almasy, L., Contreras, J., Pacheco, A., Escamilla, M. A., … Glahn, D. C. (2014). Shared genetic factors influence risk for bipolar disorder and alcohol use disorders. European Psychiatry, 29(5), 282–287. https://doi.org/10.1016/j.eurpsy.2013.10.001

Di Lorenzo, R., Galliani, A., Ferri, P., Landi, G. y Guicciardi, A. (2014). A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services. Neuropsychiatric Disease and Treatment, 10, 1479. https://doi.org/10.2147/NDT.S65896

Drake, R. E., Mueser, K. T. y Brunette, M. F. (2007). Management of persons with co-occurring severe mental illness and substance use disorder: program implications. World Psychiatry : Official Journal of the World Psychiatric Association (WPA), 6(3), 131–136. Recuperado de: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2174596&tool=pmcentrez&rendertype=abstract

Evans, E., Padwa, H., Li, L., Lin, V. y Hser, Y. I. (2015). Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment. Journal of Substance Abuse Treatment, 59, 10–19. https://doi.org/10.1016/j.jsat.2015.06.021

Fernández-Calderón, D., Fernández, F., Ruiz-Curado, S., Verdejo-García, A. y Lozano, Ó. M. (2015). Profiles of substance use disorders in patients of therapeutic communities: Link to social, medical and psychiatric characteristics. Drug and Alcohol Dependence, 149, 31–39. https://doi.org/10.1016/j.drugalcdep.2015.01.013

Ferrando, L., Gibert, J. y Lecrubier, Y. (1999). Fiabilidad y validez de la escala MINI versión CIE10. Comunicación oral. IV Congreso Nacional de Psiquiatría. Psiq Biol, 6(Suppl 2), 107.

Gual, A. (2007). Dual diagnosis in Spain. Drug and Alcohol Review, 26(1), 65–71. https://doi.org/10.1080/09595230601037000

Gutiérrez, F., Aluja, A., Peri, J. M., Calvo, N., Ferrer, M., Baillés, E., ... Krueger, R. F. (2017). Psychometric properties of the Spanish PID-5 in a clinical and a community sample. Assessment, 24(3), 326-336. htpps://doi: 10.1177/1073191115606518

Hasin, D. S. y Grant, B. F. (2015). The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Social Psychiatry and Psychiatric Epidemiology, 50(11), 1609–1640. https://doi.org/10.1007/s00127-015-1088-0

Havassy, B. E., Alvidrez, J. y Owen, K. K. (2004). Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. American Journal of Psychiatry, 161(1), 139-145. https://doi.org/10.1176/appi.ajp.161.1.139

Hobden, B., Bryant, J., Carey, M., Baker, A. L., Farrell, M., Oldmeadow, C., … Sanson-Fisher, R. (2018). Finding the optimal treatment model: A systematic review of treatment for co-occurring alcohol misuse and depression. Australian and New Zealand Journal of Psychiatry, 00(0). https://doi.org/10.1177/0004867418758922

Horsfall, J., Cleary, M., Hunt, G. E. y Walter, G. (2009). Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): A review of empirical evidence. Harvard Review of Psychiatry, 17(1), 24–34. https://doi.org/10.1080/10673220902724599

Kessler, R. y Chiu, W. (2005). Prevalence, Severity, and Comorbidity of Twelve-month DSM-IV Disorders in the National Comorbidity Survey Replication (NCS- R). Archives of General Psychiatry, 62(6), 617–627. https://doi.org/10.1001/archpsyc.62.6.617.

Maples, J. L., Carter, N. T., Few, L. R., Crego, C., Gore, W. L., Samuel, D. B., … Miller, J. D. (2015). Testing whether the DSM-5 personality disorder trait model can be measured with a reduced set of items: An item response theory investigation of the personality inventory for DSM-5. Psychological Assessment, 27(4), 1195–1210. https://doi.org/10.1037/pas0000120

McGovern, M. P., Lambert-Harris, C., Gotham, H. J., Claus, R. E. y Xie, H. (2014). Dual diagnosis capability in mental health and addiction treatment services: An assessment of programs across multiple state systems. Administration and Policy in Mental Health and Mental Health Services Research, 41(2), 205–214. https://doi.org/10.1007/s10488-012-0449-1

Najt, P., Fusar-Poli, P. y Brambilla, P. (2011). Co-occurring mental and substance abuse disorders: A review on the potential predictors and clinical outcomes. Psychiatry Research, 186(2–3), 159–164. https://doi.org/10.1016/j.psychres.2010.07.042

Padwa, H., Guerrero, E. G., Braslow, J. T. y Fenwick, K. M. (2015). Barriers to Serving Clients With Co-occurring Disorders in a Transformed Mental Health System. Psychiatric Services, 66(5), 547–550. https://doi.org/10.1176/appi.ps.201400190

Preti, E., Prunas, A., Ravera, F. y Madeddu, F. (2011). Polydrug abuse and personality disorders in a sample of substance-abusing inpatients. Mental Health and Substance Use: Dual Diagnosis, 4(3), 256–266. https://doi.org/10.1080/17523281.2011.577751

Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D. y Seay, K. D. (2016). Treatment Access Barriers and Disparities Among Individuals with Co-Occurring Mental Health and Substance Use Disorders: An Integrative Literature Review. Journal of Substance Abuse Treatment, 61, 47–59. https://doi.org/10.1016/j.jsat.2015.09.006

Radhakrishnan, R., Wilkinson, S. T. y D’Souza, D. C. (2014). Gone to pot–a review of the association between cannabis and psychosis. Frontiers in psychiatry, 5, 54. https://doi.org/10.3389/fpsyt.2014.00054

Roncero, C., Barral, C., Rodríguez-Cintas, L., Pérez-Pazos, J., Martinez-Luna, N., Casas, M., … Grau-López, L. (2016). Psychiatric comorbidities in opioid-dependent patients undergoing a replacement therapy programme in Spain: The PROTEUS study. Psychiatry Research, 243, 174–181. https://doi.org/10.1016/j.psychres.2016.06.024

Roncero, C., Gómez-Baeza, S., Vázquez, J. M., Terán, A., Szerman, N., Cases, M. y Bobes, J. (2013). Perception of Spanish professionals on therapeutic adherence of dual diagnosis patients. Actas Espanolas de Psiquiatria, 41(6), 319–329. Recuperado de: https://www.ncbi.nlm.nih.gov/pubmed/24203504

San, L., Arranz, B., Guide, E. G. for D. P. C. P., Arrojo, M., Becoña, E., Bernardo, M., … Zorrilla, I. (2016). Guía de práctica clínica para el tratamiento de la patología dual en población adulta. Adicciones, 28(1), 3–5. https://doi.org/10.20882/adicciones.784

Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., . . . Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl 20), 22-33. Recuperado de: https://www.ncbi.nlm.nih.gov/pubmed/9881538

Simpson, D. D., Joe, G. W., Rowan-Szal, G. A. y Greener, J. M. (1997). Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment, 14(6), 565–572. https://doi.org/10.1016/S0740-5472(97)00181-5

Szerman, N., Vega, P., Grau-López, L., Barral, C., Basurte-Villamor, I., Mesías, B., … Roncero, C. (2014). Dual diagnosis resource needs in Spain: A national survey of professionals. Journal of Dual Diagnosis, 10(2), 84–90. https://doi.org/10.1080/15504263.2014.906195

Torrens, M., Mestre-Pintó, J. y Domingo-Salvany, A. (2015). Comorbidity of substance use and mental disorders in Europe. EMCDDA Insight. Recuperado de: http://www.emcdda.europa.eu/system/files/publications/1988/TDXD15019ENN.pdf.Comorbidity of substance use and mental disorders in Europe

Vega, P., Szerman, N., Roncero, C., Grau-López, L., Mesíasl, B., Barral, B., … Casas, M. (2015). Libro Blanco Recursos y Necesidades Asistenciales en Patología Dual. Madrid: Sanidad y Ediciones, S.L. Recuperado de: http://www.patologiadual.es/docs/libro-blanco-recursos-asistenciales-pdual2015.pdf

Wise, E. A., Streiner, D. L. y Gallop, R. J. (2017). Predicting Change in an Integrated Dual Diagnosis Substance Abuse Intensive Outpatient Program. Substance Use and Misuse, 52(7), 848–857. https://doi.org/10.1080/10826084.2016.1264970
Published
07-04-2019
How to Cite
Mancheño-Barba, J. J., Navas-León, S., Gutiérrez-Lopez, M.-L., de la Rosa-Cáceres, A., Cáceres-Pachón, P., & Lozano, O. M. (2019). Analysis of the profiles of patients with dual pathology attending addiction centers, mental health centers, and a coordinated service. Anales De Psicología / Annals of Psychology, 35(2), 233-241. https://doi.org/10.6018/analesps.35.2.345721
Section
Clinical and Health Psychology